BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38632516)

  • 21. The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.
    Liu B; Liu XY; Wang GP; Chen YX
    Sci Rep; 2024 Mar; 14(1):5184. PubMed ID: 38431660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the role of lactylation-related genes in osteosarcoma: A deep dive into prognostic significance and therapeutic potential.
    Sun J; Li Y; Chen R; Xie Y; Wei J; Li B
    Environ Toxicol; 2024 Feb; 39(2):1001-1017. PubMed ID: 38009602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma.
    Huang W; Xiao Y; Wang H; Chen G; Li K
    Front Endocrinol (Lausanne); 2022; 13():1047433. PubMed ID: 36387908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prognostic Model Established by the Differential Expression Genes Based on CD8
    Chen Y; Yan W; Wang H; Ou Z; Chen H; Huang Z; Yang J; Liu B; Ou F; Zhang H
    Mediators Inflamm; 2023; 2023():6563609. PubMed ID: 36816742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of long noncoding RNA AC083900.1 and RP11-283C24.1 for prediction of progression of osteosarcoma.
    Huang L; Jin W; Bao Y; Zeng X; Zhang Y; Zhou J; Peng H
    Mutat Res; 2023; 827():111828. PubMed ID: 37437507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-cell RNA-seq reveals T cell exhaustion and immune response landscape in osteosarcoma.
    Fan Q; Wang Y; Cheng J; Pan B; Zang X; Liu R; Deng Y
    Front Immunol; 2024; 15():1362970. PubMed ID: 38629071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of intercellular communication in the osteosarcoma microenvironment based on single cell sequencing data.
    Chen F; Liu J; Yang T; Sun J; He X; Fu X; Qiao S; An J; Yang J
    J Bone Oncol; 2023 Aug; 41():100493. PubMed ID: 37501717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
    Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
    Front Immunol; 2022; 13():992266. PubMed ID: 36405691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
    Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
    Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SELPLG Expression Was Potentially Correlated With Metastasis and Prognosis of Osteosarcoma.
    Wang B; Sun Y
    Pathol Oncol Res; 2022; 28():1610047. PubMed ID: 35153625
    [No Abstract]   [Full Text] [Related]  

  • 32. High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification.
    Jiang X; Tang F; Zhang J; He M; Xie T; Tang H; Liu J; Luo K; Lu S; Liu Y; Lu J; He M; Wei Q
    Front Oncol; 2023; 13():991483. PubMed ID: 36845726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma.
    Huang R; Wang X; Yin X; Zhou Y; Sun J; Yin Z; Zhu Z
    Front Genet; 2022; 13():976990. PubMed ID: 36338972
    [No Abstract]   [Full Text] [Related]  

  • 34. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
    Tian K; Qi W; Yan Q; Lv M; Song D
    Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anoikis-related gene signature predicts survival and correlates with immune infiltration in osteosarcoma.
    Li J; Wang H; Wu F; Yao J; Zhu H; Zhang M
    Aging (Albany NY); 2024 Jan; 16(1):665-684. PubMed ID: 38217543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploration of s new biomarker in osteosarcoma and association with clinical outcomes:
    Xu Y; Chen P; Liu D; Xu Q; Meng H; Wang X
    J Gene Med; 2023 Nov; 25(11):e3528. PubMed ID: 37246449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
    Hong X; Fu R
    PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
    Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
    Gene; 2024 May; 907():148286. PubMed ID: 38367852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma.
    Chen D; Wan B; Cheng Y; Luo Y; Bai X; Guo J; Li G; Jin T; Nie J; Liu W; Wang R
    PeerJ; 2023; 11():e15814. PubMed ID: 37663298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating artificial intelligence in osteosarcoma prognosis: the prognostic significance of SERPINE2 and CPT1B biomarkers.
    Qu H; Jiang J; Zhan X; Liang Y; Guo Q; Liu P; Lu L; Yang Y; Xu W; Zhang Y; Lan S; Chen Z; Lu Y; Ou Y; Qin Y
    Sci Rep; 2024 Feb; 14(1):4318. PubMed ID: 38383657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.